1. Home
  2. IFRX vs FSI Comparison

IFRX vs FSI Comparison

Compare IFRX & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InflaRx N.V.

IFRX

InflaRx N.V.

HOLD

Current Price

$0.99

Market Cap

86.0M

Sector

Health Care

ML Signal

HOLD

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$6.53

Market Cap

86.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFRX
FSI
Founded
2007
1991
Country
Germany
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
86.0M
86.6M
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
IFRX
FSI
Price
$0.99
$6.53
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$9.80
N/A
AVG Volume (30 Days)
7.6M
58.2K
Earning Date
11-10-2025
11-14-2025
Dividend Yield
N/A
1.57%
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$73,729.00
$38,563,427.00
Revenue This Year
N/A
$11.26
Revenue Next Year
$1,216.24
$52.79
P/E Ratio
N/A
$45.58
Revenue Growth
N/A
0.18
52 Week Low
$0.71
$3.46
52 Week High
$2.82
$11.48

Technical Indicators

Market Signals
Indicator
IFRX
FSI
Relative Strength Index (RSI) 39.78 31.17
Support Level $1.15 $6.55
Resistance Level $1.28 $7.19
Average True Range (ATR) 0.14 0.46
MACD -0.02 -0.06
Stochastic Oscillator 1.21 11.62

Price Performance

Historical Comparison
IFRX
FSI

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

Share on Social Networks: